John Miller, MD
Ophthalmology · Boston, MANPI 1306075734
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $83,507 of the $106,405 with a category attached, or 78.5%. Alcon accounts for 75.1% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2023 at $29,832 and has fallen 86.7% since, to $3,980 in 2025. Among ophthalmology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 137 payments — averaging $776.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$80K
- Carl Zeiss Meditec, Inc.$9K
- Alcon Research LLC$9K
- Boehringer Ingelheim$3K
- Topcon Healthcare, Inc.$3K
- Sunovion Pharmaceuticals Inc.$1K
- plus $1K from 12 others
Across 3 payments — averaging $6860.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$21K
What the payments were for
- Consulting fees$83,50778%
- Speaking & faculty fees$6,9407%
- Travel & lodging$6,2566%
- Food & beverage$9,6139%
- Education$180%
- Entertainment$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 92 | $79,896 |
| Carl Zeiss Meditec, Inc. | 10 | $9,461 |
| Alcon Research LLC | 7 | $9,200 |
| Boehringer Ingelheim | 2 | $2,994 |
| Topcon Healthcare, Inc. | 1 | $2,500 |
| Sunovion Pharmaceuticals Inc. | 1 | $1,225 |
| Regeneron Healthcare Solutions, Inc. | 5 | $436 |
| Samsara Vision | 2 | $147 |
| Regeneron | 1 | $107 |
| Genentech, Inc. | 4 | $78 |
| Genentech USA, Inc. | 5 | $72 |
| Optos, Inc. | 1 | $72 |
| Boston Scientific | 1 | $56 |
| Apellis Pharmaceuticals, Inc. | 1 | $56 |
| Alimera Sciences, Inc. | 1 | $31 |
| Optovue, Inc. | 1 | $26 |
| Neurotech Pharmaceuticals, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Constellation$53,962
- NGENUITY$14,231
- Luxor$11,773
- Alcon Greishaber Finesse$11,200
- FORUM$5,847
- VERACITY SURGICAL$5,847
- Unity$3,467
- CIRRUS HD-OCT$2,860
- CLARUS$1,645
- KYNMOBI$1,225
- VisuMax$811
- FINESSE SHARKSKIN$700
- Viscoat$700
- IOLMaster 700$680
- EYLEA$359
- EYLEA HD$135
- Centurion$119
- Implantable Miniature Telescope$114
- ARTEVO 800$101
How this compares
$106,405 in reported general payments places this provider in the 95th percentile of 653 ophthalmology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 77 | $3,324 |
| Ketorolac Tromethamine | 91 | $1,619 |
| Dorzolamide Hcl | 26 | $619 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 36 | $601 |
| Latanoprost | 19 | $304 |
| Brimonidine Tartrate | 14 | $199 |
| Timolol Maleate | 16 | $168 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Boston
- Rishi SinghBoston$1.7M
- Adam RogersBoston$316K
- Bonnie HendersonBoston$279K
- Dean EliottBoston$250K
- Mina FarahaniBoston$227K
- Jia YinBoston$173K
- Elizabeth RossinBoston$101K
- Suzanne FreitagBoston$96K
- Nimesh PatelBoston$94K
- Michael RaizmanBoston$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.